Diabetic cardiomyopathy (DCM), although a distinct clinical entity, is also a part of the
diabetic atherosclerosis process. It may be independent of the coexistence of ischemic heart …

Lipid abnormalities in diabetic patients are likely to play an important role in the
development of atherogenesis. These lipid disorders include not only quantitative but also …

BACKGROUND Previous studies have demonstrated that cardiovascular risk is higher with
increased lipoprotein (a)[Lp (a)]. Whether Lp (a) concentration is related to type 2 diabetes is …

Aims/hypothesis The aim of the study was to clarify whether a therapeutic intervention
focused on lifestyle modification affected the incidence of vascular complications in patients …

Aims To examine the relations between genetic loci, plasma lipoprotein (a)[Lp (a)] levels,
and cardiovascular disease (CVD) risk among diabetic patients and compare with the …

Elevated Lipoprotein(a) Levels in South Asians in North America Page 1 Elevated
Lipoprotein(a) Levels in South Asians in North America Sonia S, Anand, Enas A, Enas, Janice …

Abstract Lipoprotein (a)[Lp (a)] represents an LDL-like particle to which the Lp (a)-specific
apolipoprotein (a) is linked via a disulfide bridge. It has gained considerable interest as a …

Lipoprotein(a): novel target and emergence of novel therapie... : Current Opinion in
Endocrinology, Diabetes and Obesity Lipoprotein(a): novel target and emergence of novel …

Patients with diabetes mellitus have a higher rate of mortality than the general population.
This higher mortality may be attributed mainly to cardiovascular disease. A high prevalence …

Background Limited evidence suggests that surgical and non-surgical obesity treatment
differentially influence plasma Lipoprotein (a)[Lp (a)] levels. Further, a novel association …